BioNTech To Buy Novartis’ GMP German Manufacturing Site For COVID-19 Vaccine Production

(RTTNews) – BioNTech SE (BNTX) announced Thursday that it has signed a share purchase deal to buy Novartis AG’s GMP certified manufacturing facility in Marburg, Germany. The company, which expects the facility to be fully operational in the first half 2021, aims to expand its CO

Want to know more on

click here go to market news source.
Market news summary from Nasdaq Market News.
Author: RTTNews

Follow us get Market News Update
Close

Market News Language